Who Owns Orchestra BioMed Stock?
NASDAQ: OBIOHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 47.80%
- Held by insiders
- 24.42%
- Institutional holders
- 112
- Institutions 47.8%
- Insiders 24.4%
- Public and other 27.8%
Who owns Orchestra BioMed stock?
Institutional investors own about 47.8% of Orchestra BioMed's shares, spread across 112 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 24.42% of OBIO.
The largest institutional holders are RTW Investments LP (15.90%), Perceptive Advisors Llc (8.38%) and Blackrock Inc. (4.18%). Together, the top 10 institutions control 39.3% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their OBIO positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of OBIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RTW Investments LP | 9.56M | 15.90% | +15.1% |
| Perceptive Advisors Llc | 5.04M | 8.38% | 0.0% |
| Blackrock Inc. | 2.51M | 4.18% | +294.9% |
| Vanguard Capital Management LLC | 2.02M | 3.37% | -8.2% |
| Geode Capital Management, LLC | 1.01M | 1.68% | +107.6% |
| Alyeska Investment Group, L.p. | 1.00M | 1.66% | 0.0% |
| Propel Bio Management, LLC | 896.70K | 1.49% | 0.0% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 642.15K | 1.07% | +100.0% |
| State Street Corporation | 516.05K | 0.86% | +204.6% |
| Rice, Hall, James & Associates LLC | 424.00K | 0.71% | +2131.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of OBIO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.47M | 2.45% |
| iShares Trust-iShares Russell 2000 ETF | 818.30K | 1.36% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 498.63K | 0.83% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 428.76K | 0.71% |
| iShares Trust-iShares Russell 2000 Growth ETF | 377.15K | 0.63% |
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | 219.39K | 0.37% |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 206.13K | 0.34% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 178.32K | 0.30% |
| iShares Trust-iShares Micro-Cap ETF | 135.78K | 0.23% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 135.54K | 0.23% |
Frequently asked questions
Who is the largest shareholder of Orchestra BioMed?
RTW Investments LP is the largest institutional shareholder of OBIO, owning 15.90% of shares outstanding (9.56M shares) as of its latest 13F filing.
What percentage of Orchestra BioMed is owned by institutions?
Institutions own about 47.8% of OBIO shares and 63.2% of the public float.
How much of Orchestra BioMed do insiders own?
Insiders, such as officers and directors, own about 24.42% of OBIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.